Search

This textbook presents real-world cases and discussions that introduce the various psychiatric syndromes found in the aging population before delving into the core concepts covered by geriatric psychiatry curricula. The text follows each case study with the vital information necessary for physicians in training, including key features of each disorder and its presentation, practical guidelines for diagnosis and treatment, clinical pearls, and other devices that are essential to trainees in geriatric psychiatry. With the latest DSM-5-TR guidelines and with rich learning tools that include key points, review questions, tables, and illustrations, this text is the only resource that is specifically designed to train both US and Canadian candidates for specialty and subspecialty certification or recertification in geriatric psychiatry. It will also appeal to audiences worldwide as a state-of-the-art resource for practice guidance. The text meets the needs of the future head on with its straightforward coverage of the most frequently encountered challenges, including neuropsychiatric syndromes, psychopharmacology, elder care and the law, substance use disorders, psychiatric comorbidities in systemic medical illness, consultation-liaison psychiatry, palliative care, climate change and health, and equity/diversity/inclusion matters in the care of older adults. Written by experts in the field, Geriatric Psychiatry: A Case-Based Textbook, 2nd edition will be the ultimate resource for graduate and undergraduate medical students and certificate candidates providing mental health care for aging adults, including psychiatrists, psychologists, geriatricians, primary care and family practice doctors, neurologists, social workers, nurses, and others.

This innovative book offers a multidimensional exploration of the epistemological foundations of psychiatry and its major disorders. By emphasizing the importance of phenomenology in unravelling the intricate interplay between basic categories of human experience and neurobiological processes, it advocates for a shift in both psychiatric research and clinical practice. Phenomenological Neuropsychiatry presents psychiatry as a hybrid discipline that synthesizes subjective mental experiences with objective neuroscientific findings and forms an integrative and interdisciplinary structure that provides a dialectical bridge between understanding, compassion, and explanation. The first section of the book presents the lived experience of psychosis and argues for a more inclusive approach to mental health issues. The second section examines the ways in which psychiatric knowledge is constructed and the unique challenges posed by combining understanding and explanation of mental disorders. Section three sheds light on how disruptions in bodily experiences, memory processes, and self-perception can contribute to the development and manifestation of psychiatric issues. The following section discusses disorders of mood and anxiety, including the phenomena of depression, obsessions, and depersonalization. The fifth and final section provides an in-depth examination of psychotic disorders. It covers a range of topics, such as timing, intentionality, self-monitoring of action in schizophrenia, and the neurobiology of prodromal psychosis. As a singular work dedicated to revitalizing and advancing cross-fertilization between psychiatry and phenomenology, this groundbreaking book clears the foggy operationalized clusters of mental symptoms that may obscure diagnosis and treatment and argues for systematic integration of patient subjectivity and collaboration in clinical research. It features an authorship of the leading clinicians and thinkers from throughout the world in psychiatry, psychology, neuroscience, social sciences, and philosophy. Phenomenological Neuropsychiatry: How Patient Experience Bridges the Clinic with Clinical Neuroscience is a major contribution to the clinical literature and a must-read for psychiatrists, neurologists, psychologists, and professionals and students from other disciplines concerned with absorbing a deeper understanding of psychiatric disorders.

This unique, ground-breaking book is a comprehensive clinical guide to the psychiatric disorder of Delusional Infestation (DI). DI is a psychiatric illness characterized by patients holding a monothematic fixed belief of infestations on their skin, body, or immediate environment - a belief that is not supported by objective medical evidence. Delusional beliefs may be shared among individuals, and perceived pathogens include living organisms such as parasitic worms, bacteria, fungi, and insects. Organic or non-organic infiltration by fibres, threads, or other inanimate particles or objects, known or unknown to medical science, are also described by patients. DI is severely underreported because of social stigma, limited physician awareness, and patient doctor-hopping.Written for physicians, the book offers a multidisciplinary, compassionate care model for patients burdened by this pernicious disorder. Other health professionals and administrators will find the work highly valuable, as will professionals in fields such as veterinary medicine, pest management, entomology, parasitology, and information services supported by academia.The Physician's Guide to Delusional Infestation assembles and organizes all current knowledge of DI and presents material in three parts. Part I introduces and reviews DI's historical background, showing how our understanding of the condition has developed. Its concise sections include useful tables, illustrations, algorithms, and reference lists for clinicians who work with DI patients.Part II covers differential diagnosis, treatment, and ways to work effectively with DI patients. Since these patients are often high-functioning, particular techniques of interviewing, joining with patients, sampling, and laboratory testing are explained. International travel, physician fallibilities, possible alternative diagnoses, the Internet, and veterinary and public health concerns are all addressed.PartIII is a series of chapters written by experts in their fields. This section allows each author to present personal experiences from their respective professions -- observations and opinions that show a variety of perspectives among the book's authors. Part III includes a chapter on common human parasites with their biology, behaviours, and distributions. The book will serve as a comprehensive, yet concise, reference for physicians whose patients have unusual, baffling, or implausible medical histories and physical examinations. A soon to be gold-standard resource, The Physician's Guide to Delusional Infestation equips and empowers all physicians -- and many others interested in the topic -- with an expert, comprehensive understanding of this complex disorder.

This book is a comprehensive guide to pediatric psychopharmacology, detailing medications used to treat a wide variety of childhood and adolescent mental illnesses. Childhood and adolescence represent critically important life stages in cognitive, social, and emotional development. Unfortunately, the prevalence of mental illness has been growing over the last several decades, especially among children. It is estimated that suicide is the second most common cause of death among adolescents and young adults in the United States. A crucial component of evidence-based mental health treatment of youth consists of careful, sophisticated, and compassionate medication treatment. This guide is divided into 18 chapters, with most covering the medications used to treat a specific disorder or group of disorders. Chapters comprehensively cover each medication's history, FDA indication status and context, representation in the media, mechanism, extent of usage and research, and quality of evidence supporting its efficacy and safety. Chapters also cover approaches clinicians can use to discuss medications with patients—including alternative treatment options and integrating patient-level variables when choosing a medication. This book focuses on understanding patient and family perspectives on medication with suggested clinician responses to better communicate about prescription management. Chapters also include tables and figures, list resources and guidelines, and discuss controversies in the media. All prescribers to children and adolescents will find Pediatric Psychopharmacology Evidence to be a timely, comprehensive, and compassionate guide to the pharmacological treatment of young patients with mental illness.

This practical, case-based book offers an approach to diagnosis and treatment of movement disorders in the outpatient setting. The major hypokinetic and hyperkinetic disorders are considered in turn, with more than 1,000 videos illustrating the role of phenomenology in the diagnosis and treatment of these conditions. Discussion of the role of ancillary testing (imaging, genetic testing) and treatment options with medications, botulinum toxin injections, and surgical intervention are woven in to the discussion of cases throughout the book. Special attention is directed to pitfalls and perils of office-based practice. This volume will be of interest to movement disorders neurologists and trainees, general neurologists, neurology residents, and any healthcare professional with an interest in exploring the application of the many treatments that have transformed movement disorders into a therapeutic field. Rather than a textbook of movement disorders, thisvolume will help the practicing clinician in guiding the thought process for evaluation and management of patients in the clinic.

neurology A fully updated and authoritative neurology resource The Queen Square Textbook has established itself as a favourite companion to clinical neurosciences training and teaching around the world, whilst retaining its role as an invaluable reference guide for physicians and other healthcare professionals working in neurology, general medicine and related specialties. The book continues to reflect the core values essential to the practice of clinical neurology in the 21st century. The third edition has been extensively revised and updated to take account of the rapid pace of progress in the neurosciences and patient care. Contemporary neurology has been changed by the COVID-19 pandemic, the climate emergency and the growing inequalities in healthcare resources. The new edition has been extensively revised to reflect these challenges and affords a greater emphasis on management and rehabilitation whilst continuing to reflect the coherence of a text produced from a single, closely-knit, centre of excellence. Highlights of the new edition include: An updated approach to clinical examination, decision-making and diagnosis New developments in neuroimmunology, pathology and genetics Neuropalliative care Ethical and legal issues in clinical neurology The latest developments in the understanding and management of stroke, movement disorders, epilepsy, cognitive impairment, multiple sclerosis, infections, myelopathy, anterior horn cell disease, disorders of nerve and muscle, neuro-oncology, neurological disorders of hearing, balance and vision, and the neurological care of critical illness, sleep, neuropsychiatry, pain, autonomic and urological disorders. An emphasis on treatment and rehabilitation of the person with a neurological disease The new edition marks a significant transition to reflect contemporary neurological practice during uncertain times. It mirrors the enormous changes in investigation, diagnosis and treatment that have occurred in recent years whilst maintaining the underlying principle that we do not treat diagnoses but, rather, we care for people affected by neurological disease.

Cannabidiol in Neurology and Psychiatry, Volume 177 in the International Review in Neurobiology series, highlights new advances in the field, with this new volume presenting interesting chapters on topic such as Historical perspective on the therapeutic potential of cannabidiol, Cannabidiol: pharmacodynamics pharmacokinetic, Cannabidiol and Alzheimer's disease, Cannabidiol on anxiety disorders, Cannabidiol on psychosis, Cannabidiol on autism spectrum disorders, Cannabidiol in Epilepsy, Cannabidiol in Ischemia/stroke, Cannabidiol in Depression, Cannabidiol and Abuse of drugs, and much more.Additional chapters cover Cannabidiol in fear response and PTSD, Cannabidiol and Pain. and Cannabidiol and Parkinson's disease. - Provides the authority and expertise of leading contributors from an international board of authors - Presents the latest release in the International Review on Neurobiology series - Updated release includes the latest information on Cannabidiol in Neurology and Psychiatry

This new second edition presents a completely new selection of 25 scenarios based on cases from the personal archive of Ondrej Dolezal, collected over 20 years of clinical practice. With a simple and uniquely innovative approach, this book offers a natural workflow through the chapter structure, helping junior doctors to gain confidence in reaching their clinical diagnosis. A range of different clinical scenarios and neurological conditions are examined, from cerebal palsy and other degenerative disorders, to epilepsy and headache. This book can serve as a teaching aid in a classroom setting, where the teacher introduces the case (“telling the story”, neurological examination) and the students then propose differential diagnoses and further tests. The teacher can show a representative test result to students and expect them to interpret the scan/test, as well as proposing further referrals and discussing the prognosis. Each chapter, contains visual aids in the form of Neuroexam, helping the reader gain a quick understanding of the case. Scenarios presented in this book can be used at the bedside in teaching medical students and junior doctors, and it is aimed at trainee neurologists and any non-neurologists who might encounter neurological cases in the clinic.

Written in a simple, easy-to-read style. Gives useful tips to practicing physician for managing the patient with neurological disorder. Divided into two sections to help the physicians arrive at a diagnosis and manage it properly. Section 1 includes a practical approach to neurological symptoms such as headache, dizziness, seizures, limb weakness, speech abnormality, and visual symptoms. Section 2 discusses an overview of common neurological disorders such as stroke, autoimmune neurologic disorders, movement disorders, infection of the nervous system, and the importance of dementia. Contains charts, diagrams, and pictures for easy understanding.

This thought-provoking book covers the full range of psychopharmacologic practice in textbook fashion, offering a fresh and comprehensive self-examination. Unlike conventional texts of psychopharmacology, this text speaks directly to clinicians who have started to question the limitations of psychopharmacologic claims and the rigid confines of DSM-5 diagnoses. Drawing from their clinical and research experience as well as new literature, the well-published authors provide a new perspective that encourages readers to reevaluate established practices and embrace that medication is just one component of treatment and has limits. The book could be used by psychiatric residents in their course of study, by clinical psychology students taking a psychopharmacology course, or by psychiatrists curious to get a readable but comprehensive look at new critical viewpoints in psychopharmacology that have changed since they were taught. Many neuroscience students who are looking for areview of clinical effects to guide their basic research may also find the proposed text more useful than those texts that collate clinical trials.Current texts are for specialized scientists or are part of multi-authored texts which list drugs alphabetically with no conceptual framework, or books that pretend that each biochemical drug property has a clear and known clinical result presented in cartoon style. Some lesser known texts for psychology or nursing students are not authoritative. Others aimed at patients or families are too simplistic for clinicians. The authors'goal was to create a unified text expressing their view of psychopharmacology, its evidence base, the unity of its essential principles, and its independence of DSM or ICD diagnosis.Several new history books describe the'rise and fall'of psychopharmacology, the corruption of big pharma and the failure of large controlled clinical trials. Psychopharmacology Reconsidered: A Concise Guide Exploring the Limits of Diagnosis and Treatment ensures that young clinicians are aware of and understand this critical zeitgeist but aware also of the essential core of psychopharmacology and the evidence upon which it rests.

This new edition fully updates and expands Faro and Mohamed's Functional Neuroradiology, a gold standard, comprehensive introduction to the state-of-the-art functional imaging in neuroradiology, including the physical principles and clinical applications of Diffusion, Perfusion, Permeability, MR spectroscopy, Positron Emission Tomography, BOLD fMRI and Diffusion Tensor Imaging. With chapters written by internationally distinguished neuroradiologists, neurologists, psychiatrists, cognitive neuroscientists, and physicists, Functional Neuroradiology is divided into 12 major sections, including: Diffusion and Perfusion Imaging, Magnetic Resonance Spectroscopy and Chemical Exchange Saturation Transfer Imaging, Multi-Modality Functional Neuroradiology, BOLD Functional MRI, Diffusion Tensor Imaging, Presurgical Brain Tumor Mapping, Emerging neuroimaging techniques, Functional Spine and Hydrocephalus imaging, and Neuroanatomical Gray and Whitematter Brain Atlases. This second edition is fully updated throughout and includes more than 15 new chapters on topics such as: Brain tumor Radiogenomics, CNS Tumor Surveillance and Functional MR Perfusion Imaging, CNS Machine Learning, Focused Ultrasound therapy, TBI Sports Related Injury, and CNS Lymphatic system. By offering readers a complete overview of functional imaging modalities and techniques currently used in patient diagnosis and management, as well as emerging technology, Functional Neuroradiology is a vital information source for physicians and cognitive neuroscientists involved in daily practice and research.

Seit Jahrzehnten der unangefochtene Bestseller für die Psychopharmakotherapie!Verlässlichkeit und Kompetenz zeichnet auch die 14. Auflage des Kompendiums aus. In der Neuauflage wurden sämtliche Inhalte sorgfältig überarbeitet und auf den neuesten Stand gebracht. Selbstverständlich finden Sie alle neuen Präparate mit den aktuellsten Empfehlungen und Bewertungen und die Berücksichtigung der DSM-5 Klassifikation.Das „Kompendium der psychiatrischen Pharmakotherapie“ ist der unverzichtbare Leitfaden für die Psychiatrie. Nirgendwo sonst findet man so komprimiert alles Wissenswerte rund um die Psychopharmakotherapie PLUS alles Wesentliche zu den einzelnen psychischen Störungen.

In different sections of this book the relationships between the patterns of psychological response in acute and chronic respiratory failure, as well as the epidemiology of neuropsychiatric disorders in ventilator management, are collected and analyzed. Main concepts such as “vulnerability to stress”, critical illness-psychological stress and susceptibility that may develop during NIV support, as well as the diagnosis of neuropsychiatric disorders in respiratory failure are also summarized. A section is devoted to the most frequent indications of NIV, also including a special use of NIV in pandemic and high-risk infections, as well as in several other conditions such as acute and chronic respiratory failures and neurological disorders. A summary of practical approaches for treatment and prevention in neurologic and psychiatric disorders during noninvasive mechanical ventilation, as well as the perspective in terms of outcomes, quality-of-life, palliative care is also given.The book is intended for all those healthcare professionals treating patients suffering from neurological or psychiatric disorders and who develop acute or chronic respiratory failure. Neurologists, psychiatrists, pulmonary critical care professionals, geriatricians, internists and psychologists will find in the book a valuable guide for their everyday clinical practice.

Movement Disorders in Psychiatry examines the complex interface between movement disorders and psychiatry, addressing both specific movement disorders in psychiatry and behavioral syndromes associated with diseases categorized as movement disorders. This volume provides an overview of clinical definitions and pathophysiology of movement disorders and reviews specific movement disorders associated with drugs of abuse and psychotropic medications, including tardive dyskinesia, akathisia, and neuroleptic malignant syndrome. Further chapters discuss movement disorders seen in primary psychiatric disorders, such as autism and schizophrenia, as well as diseases with concurrent movement disorder and behavioral symptoms, such as Huntington's disease, Parkinson's disease, frontotemporal dementia, Tourette's syndrome, and autoimmune conditions. Movement Disorders in Psychiatry offers an in-depth perspective on movement disorders with treatment and practical management strategies for related challenges in clinical practice.

Dieses Buch unterstützt alle Fachärzte, die Elektroenzephalographie klinisch anwenden: Es hilft dabei, klinisch brauchbare Kurven zu gewinnen und die vielfältigen EEG-Befunde zu interpretieren, aber auch dabei Fehler zu vermeiden.Die Autoren verdeutlichen die physiologischen und pathophysiologischen Grundlagen der Elektroenzephalographie und machen die Technologie behutsam verständlich: Besprochen werden die EEG-Potentiale in ihrer Normalität und in den verschiedenen Formen pathologischer EEG-Veränderungen.Das Buch wurde für die 4. Auflage grundlegend überarbeitet und aktualisiert, u.a. zu den epileptischen Erregungssteigerungen und prächirurgische Ableitungen sowie zu Medikamenteneffekten und zur Diagnostik des irreversiblen Hirnfunktionsausfalls. Neue Kapitel betreffen das Neuromonitoring auf der Intensivstation (cEEG) sowie das EEG-Mapping.

This book, Mind, Brain and Education, comprises selected topics from Neurology and Psychiatry, showing both their common ground and their differences. A special emphasis is given to the role of scientific gathering with the Mind & Brain Congress as a platform for educating younger colleagues and widening their perspectives in the field of both disciplines. With the new discipline of Psychoneuroendocrinoimmunology (PNEI) and its translation to clinical practice, our long-standing comprehensive approach to the interrelation and bridging of the mind and the brain contributes to a better understanding of this challenging topic. The reader can find new facts showing how diseases are the result of an alteration at the bio-psycho-social level. PNEI provides knowledge about the biological dynamics of conventional medicine and of the importance of lifestyle changes in order to fight disease. Written by experts in the field, the exceptional new approach provided by thisbook, makes it an innovative tool for spreading new knowledge, and implementing it in everyday clinical practice for the benefit of patients and even more so, to prevent them becoming patients in the first place.

This new, and heavily revised, edition of Psychopharmacology, provides a comprehensive scientific study of the effects of drugs on the mind and behavior. With the growing prevalence of psychiatric and behavioral disorders and the rapid advances in the development of new drug therapies, this textbook offers an essential understanding of the necessary details of drug action. The book presents its coverage in the context of the behavioral disorders they are designed to treat, rather than by traditional drug classifications, to strengthen understanding of the underlying physiology and neurochemistry, as well as the approaches to treatment. Each disorder from the major diagnostic categories is discussed from a historical context along with diagnostic criteria and descriptions of typical cases. In addition, what we presently know about the underlying pathology of each disorder is carefully described. Providing a solid foundation in psychology, neuroanatomy and physiology, the book also offers a critical examination of drug claims, as well as coverage of evidence-based alternatives to traditional drug therapies. Throughout, this text discusses how drug effectiveness is measured in both human and animal studies. Topics new to this edition include: a stronger emphasis on the environmental impacts on drug effectiveness; more on the mechanisms of adverse reactions to drugs and information on managing drug side effects; the risks and benefits of using'mood stabilizing drugs'to address behavior in youth with ADHD or ASD; and discussion of the research-to-practice gap in pharmacological care for children and adolescents. Accompanied by a robust selection of support material, this textbook is ideal for undergraduate and pre-professional students on courses in Psychopharmacology, Clinical Psychopharmacology, Drugs and Behavior. It is a valuable contribution to highlight the symbiotic relationship between psychopharmacology and the neural and behavioral sciences.

This atlas is the first fully visual reference to cover psychiatry broadly, appealing to psychiatric as well as non-psychiatric clinicians and trainees who need an easy-to-use visual resource with holistic approach to patient care. Written by expert clinicians and educators, this text describes basic clinical and scholarly information across the field utilizing an easy-to-understand format. The rich figures and tables describe etiology, pathophysiology, phenomenology, and treatment even in areas that are difficult to illustrate, including substance-related disorders, neurodegenerative diseases, personality disorders, and others. The visual approach proves valuable to some of the most innovative techniques in psychiatry, including implications for neuroimaging. Comprehensive and unique, Atlas of Psychiatry is a landmark reference for all medical practitioners looking for an intricate yet accessible visual resource.

This significantly revised fourth edition provides a practically orientated guide to interactions associated with antiseizure medications. It describes pharmacokinetic and pharmacodynamic antiseizure medication (ASM) interactions, including details of the magnitude and mechanism of interactions, and also of drug combinations that are not associated with interactions and therefore can be co-prescribed without undue concern. Presented in alphabetical order and by drug class, drug interactions that occur between ASMs and also between ASMs and non- ASMs are described in three sections: Drug interactions between ASMs; Drug interactions between ASMs and non- ASM Drugs: Interactions affecting ASMs; Drug interactions between ASMs and non ASM Drugs: Interactions affected by ASMs. The latest data on all drug interactions is presented. New agents discussed include cannabidiol, cenobamate, everolimus and fenfluramine,. Antiseizure Medication Interactions: A Clinical Guide, 4th Edition concisely presents the most recent developments and data available on the topic. Therefore, enabling physicians and allied health professionals to make more rational choices when ASM polytherapy regimens are required. It will be of interest to medical professionals in disciplines including neurology, psychiatry and pediatrics.

This book provides healthcare professionals in Critical Care setting an easy consultation guide to fight against COVID-19. The book is divided into sections: Fundamentals of COVID-19, Pneumological critical care, Neurological manifestations, Cardiovascular manifestations, Renal manifestations, Haemostasis and coagulation, Other multi-organs involvement, Principles of therapy. Each section includes: · brief pathophysiology of COVID-19 (ventilation, neurological, cardiovascular, etc.); · principles of management (enriched with flowcharts and figures); · principles of therapy; · tips and key messages. Readers can find the most updated advices on how to face the ongoing pandemic: from principles of conventional oxygen therapy, assisted and invasive mechanical ventilation in critically ill COVID-19 patients to the complications sometimes underestimated. Tables and flowcharts provided are based on current knowledge in COVID-19 to help the clinician managing COVID-19 patients by a multiple-organs prospective. Written by international key opinion leaders of each field, the book represents a point of reference for all professionals involved in the management of COVID-19 pandemic.

For more than 60 years, Merritt's Neurology has remained a trusted landmark text in clinical neurology, providing unparalleled guidance on neurologic protocols, treatment guidelines, clinical pathways, therapeutic recommendations, and imaging. The fourteenth edition reflects the state of today's practice, with fully updated content and timely new sections and chapters. With this edition, Dr. James Noble joins Drs. Elan Louis and Stephan A. Mayer as co-editor, all of whom trained at Columbia University where Dr. H. Houston Merritt wrote the initial editions of this book. Lauded for its comprehensive coverage, colorful and dynamic visual style, readability, and ease of use, this up-to-date reference is ideal for neurologists, primary care physicians, and residents alike.

This book is a practical guide in understanding how to prevent HIV transmission, to recognize risk behaviors, and to add something else to their repertoires. It aims to empower clinicians and provide a sense of security and competence with the recognition and understanding of some of the psychiatric illnesses that complicate and perpetuate the HIV pandemic that continue to persist throughout every area of the world despite the magnitude of the progress that has transformed the illness from a rapidly fatal to chronic illness that is no longer life-limiting. Missing in most of the literature on HIV is the subtle, and sometimes not so subtle, contribution of psychiatric symptoms, psychiatric illness, and risk behaviors that drive the pandemic and serve as catalysts for new infections. This practical guide provides state-of-the-art understanding of not only prevention but also a way to recognize risk behaviors, psychiatric symptoms, and psychiatric illnesses that will demystify and decode the sometimes enigmatic and frustrating reasons for nonadherence with diagnostic procedures and life-saving treatments and care. All behaviors and pathology are covered as well as the resources and treatments available. The goal of this text is to refresh knowledge on the current state of psychiatric illness management among people living with HIV, to provide a concise volume on the psychiatric aspects of HIV prevention and treatment that substantially impact the overall care of the patient, and to help understand the psychiatric catalysts of the pandemicWritten by experts in the field, HIV Psychiatry: A Practical Guide for Clinicians provides enduring guidance to medical and other professionals caring for complicated clinical patients as they face ongoing challenges in working with persons with HIV and AIDS.

This is a clinical and practical oriented textbook that will enable clinicians who have less expertise in the field of movement disorders to make a reasonably accurate diagnosis through a problem-oriented approach. This textbook includes a selective collection of topics that are relevant to practicing neurologists. Some of the best experts in the field of movement disorders from around the world have contributed to this book. Long discussions on pathology and genetics are limited in order to make the book simple, easy to comprehend, and practically useful for the day-to-day management of movement disorders.

This book provides a reference guide describing the current status of medication in all major psychiatric and neurological indications, together with comparisons of pharmacological treatment strategies in clinical settings in Europe, USA, Japan and China. In addition, it highlights herbal medicine as used in China and Japan, as well as complementary medicine and nutritional aspects. This novel approach offers international readers a global approach in a single dedicated publication and is also a valuable resource for anyone interested in comparing treatments for psychiatric disorders in three different cultural areas. There are three volumes devoted to Basic Principles and General Aspects, offering a general overview of psychopharmacotherapy (Vol. 1); Classes, Drugs and Special Aspects covering the role of psychotropic drugs in the field of psychiatry and neurology (Vol. 2) and Applied Psychopharmacotherapy focusing on applied psychopharmacotherapy (Vol. 3). These books are invaluable to psychiatrists, neurologists, neuroscientists, medical practitioners and clinical psychologists.

This book adopts a novel approach: procedures: instead of discussing the diagnostic categories of neurological syndromes, it focuses on the symptoms of common neurological presentations (especially in the emergency room or on the ward), and the diagnostic hypotheses that can be validated or rejected case by case as a result. Each chapter covers one of the main symptoms of emergencies in neurology – from transient consciousness disturbances to focal deficits, acute muscular disorders, respiratory insufficiency in neurological disorders, headaches, delirium, seizures and epileptic status, para-and tetraplegia, and head trauma, to acute functional disorders – and includes tables and figures to allow readers to gain a quick and easy, yet comprehensive overview of the topic. The book guides readers through various scenarios generated by the onset of symptoms, the clinical tools for differential diagnostics, and the principles of acute and post-acute phase therapy, managed by decision algorithms supported by the most recent scientific evidence. The resulting precedural profile – created through the collaboration of over 80 specialists in neurology or other disciplines – makes this text a valuable tool for neurologists, neurology residents and allied professionals in their daily clinical practice, as well as medical students.

This contributed volume discusses the multiple roles of astrocytes, which determine the progression and outcome of neuropsychiatric diseases. This emerging area of study examines the ways in which astrocytes are involved in various aspects of disease initiation, progression and resolution. This monograph aims to integrate the body of information that has accumulated in recent years revealing the active role of astrocytes in neuropsychiatric pathology and in psychiatric disorders. Understanding roles of astrocytes in pathology will provide new targets for medical intervention and aid the development of much needed therapeutics. This book will be valuable for researchers and workers in the fields of neurobiology, neurology, and psychiatry, as well as fill the need for a textbook used in advanced courses/graduate seminars in glial pathophysiology.

This book provides a comprehensive and practical guide to orthostatic hypotension (OH) for doctors and nurses involved in the care of older adults, together with a state-of-the-art update on OH, covering its epidemiology, pathophysiology, assessment, diagnosis, causes, prevention, management, and relevance for geriatric practice. In addition, it addresses mechanisms of orthostatic tolerance and other orthostasis related conditions, as well as drugs, comorbidities and geriatric syndromes related to OH. The homeostatic ability to maintain blood pressure while standing requires an adequate blood volume and the integrity of the nervous system, heart, blood vessels and muscle pump. However, in older adults, some age-related factors can contribute to the development of OH. For example, decreased baroreflex sensitivity, α-1-adrenergic vasoconstrictor response to sympathetic stimuli, parasympathetic activity, renal salt and water conservation, increased vascular stiffness and decreased ventricular diastolic filling, as well as concentrated capacities of the kidney may be associated with changes in postural blood pressure. It has also been shown that OH is associated with falls, cardiac events, heart failure, stroke, reduced quality of life, and increased risk of overall mortality in these patients. “Orthostatic Hypotension in Older Adults” will be of considerable interest to all professionals working in the fields of geriatrics, geriatric psychiatry, neurology, internal medicine, cardiology, and emergency medicine, or working with older people in hospitals or in their community.

The hypothalamus is an anatomically small but functionally important part of the brain. In functional and pathophysiological terms, the hypothalamus represents the intersection of several areas of clinical and medical expertise. The human hypothalamus can be astutely referred to as the crossroad of endocrinology, psychiatry, neurology and neurosurgery. Because of its involvement in myriad physiologic functions and the varied ways disorders involving it can manifest, hypothalamic disease can initially come to medical attention in widely disparate settings and with widely different clinicians. Therefore, the detection and proper care of hypothalamic dysfunction and disease often requires carefully coordinated multidisciplinary care.This volume fills a significant void in the medical professional community, comprehensively presenting the scope of hypothalamic structure, function, dysfunction and disease to cater to the various clinical, teaching and researchprofessionals that have a stake in this part of the human brain. This text captures in one place all the information that practicing clinicians, clinician scientists, and researchers need to be adequately informed about various aspects of the hypothalamus in all its complexity. It is comprehensive and broad in scope so that it provides relevant reference information for the wide range of professionals involved in the pre- and post-mortem detection, diagnosis, characterization, care and management of various hypothalamic disorders and diseases in addition to providing a sound anatomic and physiologic foundation of the normal human hypothalamus. The Human Hypothalamus can be used to differing degrees by medical professionals and students alike, finding utility for interested general clinicians, medical school and allied health professional teaching faculty as well as subspecialists in domains as wide as neurosurgery, neuroendocrinology, clinical psychiatry and neuro-oncology.

Aminoff's Neurology and General Medicine, Sixth Edition is the standard and classic reference providing comprehensive coverage of the relationship between neurologic practice and general medicine. As neurologists are asked to consult on general medical conditions, this reference provides an authoritative tool linking general medical conditions to specific neurologic issues and disorders. This is also a valuable tool for the general practitioner seeking to understand the neurologic aspects of their medical practice. Completely revised with new chapters covering neurologic complications of immunotherapies, headache and general medical disorders, back and neck pain in general medical disorders, swallowing and speech disorders, and neurological changes in the elderly, this new edition will again be the go-to reference for both neurologists and general practitioners. - The standard authoritative reference detailing the relationship between neurology and general medicine - 100% revised and updated with several new chapters including Neurologic Complications of Immunotherapies, Headache and General Medical Disorders, and Neurological Changes in the Elderly - Well-illustrated, with most illustrations in full color

With a focus on practical acute pain management in adults in the hospital setting, this book provides health professionals with simple and practical information to help them manage patients with acute pain safely and effectively. • Combines evidence-based information with practical guidelines and protocols • Covers the pharmacology of opioids, local anesthetics, and nonopioid and adjuvant analgesic agents • Discusses management of acute pain in both surgical and nonsurgical acute pain settings including in patients with spinal cord or burns injuries and selected medical illnesses • Includes evidence-based information about management of acute pain in some specific patient groups, including the older patient, opioid-tolerant patients, and those with addiction disorders, pregnant or lactating patients and patients with obstructive sleep apnea or who have renal or hepatic impairment • Considers the role of acute pain management in the context of the current opioid epidemic and identifies possible strategies to minimise the risks. This resource will be helpful to a variety of professionals in assessing and managing acute pain.

Movement Disorders in Childhood, Third Edition provides the most up-to-date information on the diseases and disorders that affect motor control, an important area of specialization within child neurology. In this new edition, each chapter has been fully revised to include all of the latest scientific and therapeutic advances. Updates include new insights in motor development, control, goal-directed and habitual behaviors, classifications of movements and their complex and integrated circuitry. The authors also discuss developments in pathophysiologic mechanisms, immunology and metabolic disorders. New chapters include coverage of genetics of movement disorders and movement disorders in psychiatric conditions.Appendices include an updated and revised drug index and genetic search strategy. An updated Companion website hosts selected educational videos to help diagnose movement disorders. - Provides the only current reference specifically focused on childhood movement disorders - Investigates the underlying etiologies and mechanisms of these disorders - Revised and updated with new materials and a more disease-oriented approach - Contains new chapters on the genetics of movement disorders and movement disorders in psychiatric conditions - Includes new videos of instructive and unusual childhood movement disorders

Offering a state-of-the-art, authoritative summary of the most relevant scientific and clinical advances in the field, Principles and Practice of Movement Disorders provides the expert guidance you need to diagnose and manage the full range of these challenging conditions. Superb summary tables, a large video library, and a new, easy-to-navigate format help you find information quickly and apply it in your practice. Based on the authors'popular Aspen Course of Movement Disorders in conjunction with the International Parkinson and Movement Disorder Society, this 3rd Edition is an indispensable resource for movement disorder specialists, general neurologists, and neurology residents. - Explores all facets of movement disorders, including the latest rating scales for clinical research, neurochemistry, clinical pharmacology, genetics, clinical trials, and experimental therapeutics. - Provides the essential information you need for a clinical approach to diagnosis and management, with minimal emphasis on basic science. - Reflects recent advances in areas such as the genetics of Parkinsonian and other movement disorders, diagnostic brain imaging, new surgical approaches to patients with movement disorders, and new treatment guidelines for conditions such as restless legs syndrome. - Features a reader-friendly, full-color format, with plentiful diagrams, photographs, and tables. - Includes access to several hundred updated, professional-quality video clips that illustrate the manifestations of all the movement disorders in the book along with their differential diagnoses.

This ambitious and comprehensive handbook represents an essential contribution to our current understanding of interactions between heart and brain, a research topic generating growing interest. Despite the increasing awareness that neural mechanisms are the primary cause of cardiac disease and its progression, therapy continues to focus on end-organ protection and does not approach the neural core of the problem. Growing public health problems such as heart failure are still treated with autonomic drugs that are 30-40 years old and simply act on cardiac receptors. However, it has now been shown that the progression of ischemic heart disease to heart failure is mainly due to abnormal central responses to incipient cardiac disease, with neural activation the primary cause rather than the consequence of cardiac remodeling. Written by leading international experts in their respective research areas, the book presents a variety of perspectives on the coretopic: from social and philosophical to gender-related aspects.It is designed for a broad readership and includes dedicated sections for cardiologists, psychiatrists, neurologists and psychotherapists looking for a more insightful and targeted approach to neuro-cardiovascular disease.

Management of Sleep Disorders in Psychiatry provides the most comprehensive and evidence-based review of the clinical management of DSM-V based sleep-wake disorders in patients with psychiatric disorders. This book is organized into three sections that focus on the basics of sleep medicine, clinical features and treatment of DSM-V sleep-wake disorders, and evidence-based management of sleep disorders commonly associated with a range of DSM-V based psychiatric disorders. The first section orients the reader to topics such as sleep physiology, neural mechanisms of wakefulness and sleep, circadian rhythms, effects of sleep on cognition, history taking in sleep medicine, and clinical application of technical procedures used in the field of sleep medicine. The second section adopts a unique perspective of using DSM-V classification of sleep-wake disorders to integrate the management of sleep disorders with mainstream clinical psychiatry. This section features a comprehensive chapter on pediatric sleep-wake disorders, a topic of interest to fellows and practicing clinicians specializing in child and adolescent psychiatry. The third section offers the most comprehensive review of comorbidity, shared pathophysiology, and clinical management of sleep disorders within the context of a wide range of DSM-V based psychiatric disorders. This section also highlights important topics such as delirium, neurocognitive disorders, effects of psychotropic medications on sleep, neurological disorders, pain disorders, forensic sleep medicine, and eating disorders. This clinically-oriented resource provides case vignettes and clinical pearls to illustrate the diagnosis and treatment of sleep disorders in the setting of a variety of psychiatric presentations. Additionally, each chapter includes a self-assessment section with multiple-choice questions that helps the reader solidify their clinical skills and prepare for the board and certification examinations for topics pertinent to sleep-wake disorders in psychiatry.

Here is a comprehensive overview of the drugs that act on the central and peripheral nervous systems. This volume thoroughly describes the diseases associated with the nervous system and the drugs used for their treatment while also looking at the current status of these drugs and their future potential and challenges.Divided into three sections, the book first focuses on the drugs that affect the functions of the autonomic nervous system to produce therapeutic effects. These drugs may act presynaptically by manipulating the genesis, storage, and secretion, and by blocking the action of neurotransmitters. Some drugs may trigger or impede postsynaptic receptors. Section 2 focuses on drugs that affect the central nervous system, including antianxiety drugs, sedative and hypnotic drugs, antidepressant drugs, antipsychotic drugs, antiepileptic drugs, and many more. It covers the pharmacological management of various diseases, including Alzheimer's, Parkinson's, Huntington's, and others. The last section offers explanations of neurochemical interactions with the aim to develop drugs that have beneficial effects on neurochemical imbalances. This section demonstrates models to assess the transport of drugs across the blood-brain barrier and nanomedicine to treat brain disorders.This rich compilation provides thorough and extensive research updates on the important advances in neuropharmacological drugs and drug therapy from experienced and eminent academicians, researchers, and scientists from throughout the world.

Seit Jahrzehnten der unangefochtene Bestseller für die Psychopharmakotherapie!Mit der inzwischen 13. Auflage steht das Buch einmal mehr für Verlässlichkeit und Kompetenz. In der Neuauflage wurden sämtliche Inhalte sorgfältig überarbeitet und auf den neuesten Stand gebracht. Selbstverständlich finden Sie alle neuen Präparate mit den aktuellsten Empfehlungen und Bewertungen und die Berücksichtigung der DSM-5 Klassifikation.Das „Kompendium der psychiatrischen Pharmakotherapie“ ist der unverzichtbare Leitfaden für die Psychiatrie. Nirgendwo sonst findet man so komprimiert alles Wissenswerte rund um die Psychopharmakotherapie PLUS alles Wesentliche zu den einzelnen psychischen Störungen.Begleitend zum Buch gibt es einen kostenfreien Psychopharmaka-Blog (Kompendium News), der Sie über Neuerungen auf dem Laufenden hält. Jetzt erstmals in einem neuen Buchformat und mit angepasstem, modernem Layout.

A counterintuitive and novel approach to the long-sought goal of subtyping schizophrenia and other psychotic disorders emerges from ongoing research. Five psychosis associated anxiety and depressive subtypes each help define five corresponding psychosis diagnoses, their fixed false beliefs, and most importantly, their treatments. These anxiety and depressive comorbidities have long been long overlooked as an understandable hodgepodge of distressing symptoms caused by the pain of psychosis. But these five comorbidities usually precede onset of the psychosis, and their treatment can significantly improve outcome. So, maybe, the causation is the other way around: maybe they are among the underlying contributors to schizophrenia and other psychotic disorders. The chapter authors expertly detail the data supporting this innovative approach. They provide fictional case studies, DSM-5 diagnostic criteria, specific interviewing approaches for the five comorbidities in psychosis patients, and improved treatment options. Other chapters explore psychoses related to substance use, medical illness and medical treatment, as well as other factors that contribute to psychotic disorders. This first-of-its-kind reference is a valuable clinical, educational, research and training resource for psychiatrists, psychologists, nurses, social workers, neurologists and anyone interested in the care and treatment of someone with a psychotic disorder. - Reflects current research, diagnosis, and treatment options for: - Schizophrenia with Voices and Panic Anxiety - Obsessive-Compulsive Schizophrenia and Obsessive-Compulsive Disorder - Persecutory Delusional Disorder and Social Anxiety - Delusional Depression and Melancholic Depression - Bipolar I Disorder and Atypical Depression - Substance Use Psychoses - Medical Illness and Iatrogenic Psychoses - Covers treatment options and outcomes with medication and psychotherapy. - Includes sample patient interview approaches and/or biological tests for each diagnosis. - Highlights symptoms, quasi-psychotic symptoms and secondary signs of the comorbidities when alone, and when in conjunction with psychosis. - Reviews diagnosis-specific significance and contributory roles of neurotransmitters, hypofrontality, psychological trauma, and genetics.

Cet ouvrage d'experts rassemble des informations destinées aux neurologues, mais aussi à tous les professionnels de santé impliqués dans la prise en charge de ces pathologies du mouvement. Les deux premiers chapitres portent sur l'anatomie fonctionnelle des noyaux gris centraux, et sur l'imagerie des mouvements anormaux. Plusieurs autres sont réservés à la maladie de Parkinson et aux autres syndromes parkinsoniens dégénératifs. Les maladies héréditaires affectant le cervelet sont abordées également dans un chapitre spécifique Entourés des meilleurs spécialistes français, les coordinateurs, Christine Tranchant et Jean-Philippe Azulay, proposent ici un outil de travail de référence qui facilitera la démarche diagnostique et thérapeutique de ces affections.

Frontiers in Clinical Drug Research - CNS and Neurological Disorders is a book series that brings updated reviews to readers interested in advances in the development of pharmaceutical agents for the treatment of central nervous system (CNS) and other nerve disorders. The scope of the book series covers a range of topics including the medicinal chemistry, pharmacology, molecular biology and biochemistry of contemporary molecular targets involved in neurological and CNS disorders. Reviews presented in the series are mainly focused on clinical and therapeutic aspects of novel drugs intended for these targets. Frontiers in Clinical Drug Research - CNS and Neurological Disorders is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critical information for developing clinical trials and devising research plans in the field of neurology. The eighth volume of this series features reviews that cover the following topics related to the treatment of a variety of CNS disorders, related diseases and basic research: - Emerging Innovative Therapies of Spinal Muscular Atrophy: Current Knowledge and Perspectives - Obesity Induced by The Neurological Drugs - Molecular Mechanism of Nervous System Disorders and Implications for New Therapeutic Targets - Glioma Imaging and Novel Agents - Screening Models for Neuroleptic Drug-Induced Hyperprolactinemia: A Mini-Review

The definitive guide to understanding, diagnosing, and treating neurologic disease – more complete, timely, and essential than ever A Doody's Core Title for 2020! Adams and Victor's Principles of Neurology is truly the classic text in its discipline --- a celebrated volume that guides clinicians to an in-depth understanding of the key aspects of neurologic disease, including both clinical and new scientific data. This meticulously revised and updated text remains the masterwork in its field, and the most readable reference available. Within its pages, you will find a disciplined presentation of clinical data and lucid descriptions of underlying disease processes. Some of the features that have made this resource so renowned: •The most cohesive and consistent approach to clinical management – acclaimed as the most readable book in the literature •A scholarly approach that gives readers a comprehensive overview of every neurologic illness •Unmatched coverage of signs and symptoms •A focus on the full range of therapeutic options available to treat neurologic diseases, including drug therapy and rehabilitation methods •Coverage of the most exciting discoveries and hypotheses of modern neuroscience that bear on and explain neurologic disease •Puts the latest scientific discovery into a larger clinical context •An evenness of style and a uniform approach to subject matter across disciplines that allows a quick and easy review of each topic and condition •A rich, full-color presentation that includes many high-quality illustrations The Eleventh Edition is enhanced by new coverage of : •Interventional therapies for acute ischemic stroke •Novel immunotherapies used to treat inflammatory and neoplastic conditions, and neurotoxicities associated with these drugs •New drugs to treat epilepsy and multiple sclerosis •Update of genetics of inherited metabolic disease •Current understanding of the genetics of primary nervous system malignancies and their bearing on treatment

Parkinsonism beyond Parkinson's Disease, Volume 149, the latest release in the International Review of Neurobiology series, highlights new advances in the field, with this new volume presenting interesting chapters on a variety of topics, including How to approach a patient with parkinsonism – red flags for atypical parkinsonism, The ‘classic'atypical parkinsonian disorders, Classification of atypical parkinsonism per pathology vs. phenotypes, Progressive supranuclear palsy, Corticobasal degeneration, Multiple system atrophy, Atypical parkinsonism in other sporadic and genetic neurodegenerative diseases, Sporadic ‘Atypical'Parkinson's disease, and much more. Provides the authority and expertise of leading contributors from an international board of authors Presents the latest release in the International Review of Neurobiology series Updated release includes the latest information on Parkinson's Disease

Psychopharmacology of Neurologic Disease, Volume 165 in the Handbook of Clinical Neurology series, provides clinicians with an up-to-date, critical review of the best approaches to treatment of neurologic disease as discussed by experienced clinical investigators. The book is organized into sections on dementia, delirium, movement disorders, hereditary degenerative disease, epilepsy and psychogenic seizures, brain vascular disease, pseudobulbar affect, traumatic brain injury, neuro-oncology, multiple sclerosis and other demyelinating disorders, chronic fatigue syndrome/fibromyalgia, pain, headache, sleep disorders, autoimmune encephalitis/anti- NMDA encephalitis, functional sensory neurologic symptom disorders and neurodevelopmental disorders. Each of these diagnostic categories has a significant incidence of behavioral symptomatology that is secondary to the neurologic diagnosis that can serve to complicate other therapeutic interventions, alter the course of illness, and cause distress in patients and family caregivers. - Provides a systematic, evidence-based compendium of best practices in the treatment of behavioral symptomatology relating to neurologic conditions - Integrates state-of-the-art approaches in treating all behavioral symptomatology across all major neurologic disorders - Explores psychopharmacological intervention, non-pharmacological strategies, behavioral symptomatology, and therapeutic interventions

Epilepsy is one of most frequent neurological disorders affecting about 50 million people worldwide and 50% of them have at least another medical problem in comorbidity; sometimes this is a the cause of the epilepsy itself or it is due to shared neurobiological links between epilepsy and other medical conditions; other times it is a long-term consequence of the antiepileptic drug treatment. The Comorbidities of Epilepsy offers an up-to-date, comprehensive overview of all comorbidities of epilepsy (somatic, neurological and behavioral), by international authorities in the field of clinical epileptology, with an emphasis on epidemiology, pathophysiology, diagnosis and management. This book includes also a critical appraisal of the methodological aspects and limitations of current research on this field. Pharmacological issues in the management of comorbidities are discussed, providing information on drug dosages, side effects and interactions, in order to enable the reader to manage these patients safely. The Comorbidities of Epilepsy is aimed at all health professionals dealing with people with epilepsy including neurologists, epileptologists, psychiatrists, clinical psychologists, epilepsy specialist nurses and clinical researchers. - Provides a comprehensive overview of somatic, neurological and behavioral co-morbidities of epilepsy - Discusses up-to-date management of comorbidities of epilepsy - Written by a group of international experts in the field

This case series book offers a practical and accessible approach to psychiatry, addressing major clinical problems ranging from psychosis to aging effects, each of which is tackled as it arises in everyday settings. With its emphasis on everyday practice strongly linked to underlying theory, the book combines clinical knowledge with the realities of managing clinical problems, and will provide a basis for developing sound analytical and confident decision-making skills. Presenting different visions of clinical psychiatry and expanding psychiatrists'interventions by integrating innovative neuroscience approaches such as neuroimaging, neuropsychology, TMS and cognitive rehabilitation, it will help clinicians and students alike gain a sound understanding of the wide range of signs and symptoms that indicate psychiatric disorders, and how the diagnosis, management and treatment options can differ from those in other medical specialties. The volume includes learning activities, with questions on each clinical case followed by detailed explanatory answers, and self-assessment exercises to assist with learning and revision. Throughout the book, tips and key features are highlighted with boxes, algorithms, tables and figures, which the reader can refer back to for exam revision and well into her/his career.

This ambitious and important second edition of the Handbook of Medical Neuropsychology takes an in-depth approach to the medical conditions and methods of neurorehabilitation. Comprehensive in scope and highly detailed in its coverage, the second edition, like the first, characterizes the effects of disease and the impact of interventions in the current state of advanced medicine at a level appropriate both for researchers and for clinicians. Featuring the most up-to-date information and quantitative research on cognitive neuroscience of autism, HIV/AIDS, cancer, head injury, respiratory diseases, endocrine diseases, early birth injury, dementia, and other disorders, the book handles theory, historical background, practical considerations, and controversial areas with evidence based disease indicators, clinical expertise, and real-world insight. It seeks to critique diagnostic and assessment tools specific to disorders. The new chapters in this inclusive second editionreflect the changes in prominent problems found in the clinic and provide worthy insights for research investigation in their review of: Substance use disorders.Nutrition in neurocognition and mental health.Hypothyroidism and Hashimoto's thyroiditis.Traumatic brain injury in very early childhood.Cognitive functioning in asthma.The role of mindfulness in neurorehabilitation. The Handbook of Medical Neuropsychology, 2nd Edition continues to be an essential resource for the neuropsychology clinician, researcher, practitioner or graduate student. It will be stimulating and relevant reading for years to come.

This book provides basic information on neuroanesthesia, comprehensively discussing the brain and spine anatomy, physiology and relevant pharmacology. It also explores various co-existing medical conditions in neurosurgical patients and their medical management relevant to anesthesia, with each problem presented in a standard format. Written by experts in the field and including illustrations, flowcharts and images, each chapter begins with a brief clinical scenario and include the latest evidence-based information. This book is a valuable guide for all anesthetists, not only dedicated neuroanesthetists.

Smell and Taste, Volume 164 focuses on recent clinical research regarding two of our primary chemical senses, smell and taste. This volume is the most comprehensive neurology book on disorders of smell and taste function. Its major sections include epidemiology, anatomy and physiology, and clinical assessment, including neuroimaging, clinical conditions affecting smell and taste function (e.g., autoimmune disorders, head trauma, diseases of the nose and mouth, etc.). The widespread use of olfactory testing in clinical trials searching for biomarkers of neurodegenerative diseases is reviewed, along with evidence that smell dysfunction can be an early marker in neurodegenerative diseases and autoimmune disorders. - Covers all aspects of disorders of taste and smell for beginning students of various disciplines (neurology, psychiatry, neuropsychology, otolaryngology) - Teaches that smell and taste testing can be useful in differential diagnosis and can assess brain regions not normally assessed by traditional neurological or neuropsychological tests - Addresses, in detail, recent evidence that smell loss is a better predictor of future mortality than dementia and even heart disease

This book illustrates the clinical interface between neurology and psychiatry by focusing on neuropsychiatric conditions characterised by alterations at the level of both motor function and behaviour. The neuropsychiatric approach to movement disorders and epilepsy is of key importance in clinically assessing and treating these common and often disabling conditions. While addressing the clinical challenges posed by the behavioural aspects of movement disorders and epilepsy, it invites readers on a journey through the evolving discipline of neuropsychiatry / behavioural neurology – both in the past and today. This discipline has an illustrious history, and continues its ascending trajectory in the new millennium through the activity of long-established national organisations (British Neuropsychiatry Association, BNPA, and American Neuropsychiatric Association, ANPA) as well as newly developed strategic research initiatives (Michael Trimble Neuropsychiatry Research Group, MTNRG).

This book provides neurologists with a basic knowledge of psychiatric medications. It begins with general principles of psychopharmacology and the frequency of psychiatric illness in neurology patients. It goes on to cover psychoactive drugs in the elderly and treating behavioral symptoms of dementia. There is a special emphasis on drug-drug and drug-diet interactions that may be seen in clinical practice. Neurologists, residents, neuropsychiatrists, neuropsychologists and psychiatrists in training will find this practical guide invaluable in numerous clinical settings.

The aim of this textbook is to focus on the neurology. Neurology is a field in medical sciences which has made phenomenal progress over the last two decades. Advancement in technology has changed our understanding of many diseases leading to improvement of patient care. Textbooks provide rapid access to the current status of the diseases and serve as ready reference for the physicians. This textbook consists of 12 sections following as headache, neuroinfections, stroke, epilepsy, movement disorders, central nervous system demyelination, dementia and cognitive disorders, neuromuscular disorders, neurotoxicology, neurorehabilitation, recent advances, and miscellaneous, which are further divided into 111 chapters. Each section is dedicated to one subspecialty of neurology. The book chapters are comprehensive, well-written, and carry information with special emphasis on Indian scenario. It is well documented that prevalence, presentations, genetics, and treatment response of various neurological diseases have significant regional variation. The references quoted are extensive and will guide interested readers for further reading.